News | August 14, 2012

Increasing Minimally Invasive Surgeries to Boost Adoption of Hybrid ORs in Europe

August 14, 2012 — The next five years will see many hospitals in Europe overcoming the high cost and complexity of implementing hybrid operating rooms (OR) by adopting better planning and budget allocation. This will encourage hospitals with larger cardiac and neurosurgery services to implement at least one hybrid OR, suggests new analysis from Frost & Sullivan.

Hybrid ORs combine conventional surgical equipment with endovascular imaging equipment to facilitate a multitude of new surgical events for many medical disciplines. Currently, Europe has very few hybrid ORs in comparison to mature markets such as North America. This is set to change as hybrid ORs facilitate sophisticated surgeries while reducing hospitalization periods. “Operating Rooms of the Future: A European Perspective” finds that the crisscrossing of disciplines, coupled with booming demand for minimally invasive surgeries, will boost adoption of the hybrid OR.

The key restraint to the uptake of hybrid ORs is cost. The expense involved in setting up a hybrid suite can vary between $3 million to $9 million, including the heavy investment in large devices like angiography imaging systems, magnetic resonance imaging (MRI) or computed tomography (CT) scanners. In Europe, installation costs alone start at $4 million for an empty site.

"Hybrid OR is perceived as an expensive alternative to traditional operating rooms, mainly due to the high initial investment," said Somsainathan C. Kamalasekar, research analyst at Frost & Sullivan. "Currently, European countries are struggling to overcome the economic crisis, and such investments are not seen as attractive or critical areas that demand immediate budgets. Due to lack of funds, hybrid OR is witnessing a lower adoption rate than its actual potential."

However, most operating theaters are running at an average of 68 percent of their capacity, even though it is the largest revenue and cost-generating center for a hospital, accounting for approximately 42 percent of the average healthcare organization's revenue and a proportionate share of its costs. A hybrid OR will allow both human and technical resources to be employed optimally. Thus, integration of a hybrid OR into the central surgical department generates the most advantages, since a hybrid OR allows interdisciplinary applications and is available as an operating room resource.

"Practically, once the hybrid is set up, the hospital can save costs through its use and additionally optimize the selection and quality of treatment routines. This also increases patient and staff satisfaction," said Somsainathan. "Educating and increasing the awareness about the benefits of hybrid OR, as well as targeting the private hospitals that have sufficient funds, will help in the short run."

For more information: www.frost.com

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init